True Health Diagnostics - Health Diagnostic Laboratory

True Health Diagnostics is a privately held health services company operated by True Health Group, LLC, an organization of healthcare entities providing medical services. Headquartered in Frisco, Texas, True Health specializes in earlier-stage prevention and diagnosis of chronic disease, including cardiovascular disease, diabetes, cancer, genetic disorders and a range of metabolic conditions. The company's laboratory can detect conditions not apparent through customary diagnostic tests. It provides healthcare organizations with comprehensive testing for early detection of chronic diseases. The company maintains CLIA-certified, CAP-accredited laboratory facilities in the North Texas Enterprise Center in Frisco and in the Virginia BioTechnology Research Park in Richmond, Virginia.

History

True Health Diagnostics was founded by Chris Grottenthaler in March 2014 as a specialty lab that would specialize in early stage identification of diseases. The company began operations in October 2014.

True Health purchased the assets of Health Diagnostic Laboratory, Inc. at a court-supervised auction, in September 2015 for $37.1 million. The sale was approved by Judge Kevin Huennekens of the United States Bankruptcy Court for the Eastern District of Virginia the same month. True Health did not assume HDL’s liabilities as part of the sale. True Health Diagnostics voluntarily assumed a corporate integrity agreement when it acquired HDL’s assets which requires an independent review of its compliance program and a comprehensive report to the Office of Inspector General.

Becker's Hospital Review named True Health Diagnostics to its "150 Great Places to Work in Healthcare" list in February 2017.

Products and Services

True Health provides chronic disease detection and management to medical professionals and patients with cardiovascular illness, cancer, diabetes and others. The laboratory uses biomarkers to assess a patient’s health and do more than 100 assays for chronic diseases. Once a diagnosis is made, the company also provides services including online disease prevention programs, and wellness education programs and nutrition plans.

True Health Outreach, an affiliate of True Health Diagnostics, provides hospitals with laboratory management services as well as access to systems of patient engagement. The program was introduced in December 2016.

Research

In 2016, Harvard Medical School completed a study of omega-3 fatty acids on heart function in patients who have suffered a heart attack, which was published in the journal Circulation, a publication of the American Heart Association, in 2016. True Health Diagnostics provided researchers with proprietary testing services that underpinned the study.

References

External links

• Official website
• Official blog